Table 4.
EQ-5D VAS scores and utility values by male patients with and without GW and female patients with and without selected HPV-related disease in South Korea
| Men (n=150) | ES | P value | Overall | Women (n=250) | ES | P value | Overall | |||
| With GW (n=75) |
No GW (n=75) |
HPV disease (n=200) |
No HPV disease (n=50) |
|||||||
| VAS (EQ-5D) | ||||||||||
| Mean | 75.31 | 81.13 | 0.41 | 0.0135 | 78.16 | 72.18 | 76.86 | 0.30 | 0.0606 | 73.14 |
| 95% CI | (71.6 to 79.0) | (78.4 to 83.9) | (75.8 to 80.5) | (69.9 to 74.4) | (72.6 to 81.1) | (71.2 to 75.1) | ||||
| Valid, n | 74 | 71 | 145 | 190 | 49 | 239 | ||||
| Utility values | ||||||||||
| Mean | 0.95 | 0.95 | <0.01 | 0.7527 | 0.95 | 0.90 | 0.94 | 0.27 | 0.0773 | 0.91 |
| 95% CI | (0.9 to 1.0) | (0.9 to 1.0) | (0.9 to 1.0) | (0.9 to 0.9) | (0.9 to 1.0) | (0.9 to 0.9) | ||||
| Valid, n | 75 | 75 | 150 | 199 | 50 | 249 | ||||
CECA scores range from 0 (worst HRQoL) to 100 (the best HRQoL).
EQ-5D range from 0 (worst imaginable health state) to 100 (best imaginable health state).
HIP items range from 0 (lowest impact) to 10 points (highest impact).
ES >0.01 is considered significant.
CECA, Cuestionario Especifico en Condilomas Acuminados; EQ-5D, EuroQol-5 Dimension; ES, effect size; GW, genital warts; HIP, Human Papillomavirus Impact Profile; HPV, human papillomavirus; HRQoL, health-related quality of life; VAS, Visual Analogue Scale.